IL106854A - Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard - Google Patents

Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard

Info

Publication number
IL106854A
IL106854A IL10685487A IL10685487A IL106854A IL 106854 A IL106854 A IL 106854A IL 10685487 A IL10685487 A IL 10685487A IL 10685487 A IL10685487 A IL 10685487A IL 106854 A IL106854 A IL 106854A
Authority
IL
Israel
Prior art keywords
compounds
immune response
pentoxifylline
formula
acid
Prior art date
Application number
IL10685487A
Other languages
English (en)
Hebrew (he)
Original Assignee
Hoechst Roussel Pharma
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma, Univ Virginia filed Critical Hoechst Roussel Pharma
Publication of IL106854A publication Critical patent/IL106854A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL10685487A 1986-12-31 1987-12-23 Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard IL106854A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94790586A 1986-12-31 1986-12-31
IL8493487A IL84934A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines

Publications (1)

Publication Number Publication Date
IL106854A true IL106854A (en) 1996-05-14

Family

ID=25486973

Family Applications (7)

Application Number Title Priority Date Filing Date
IL10685487A IL106854A (en) 1986-12-31 1987-12-23 Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard
IL10053687A IL100536A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine Stopping an immune response and relieving adverse conditions resulting from intracellular intervention in an immune response
IL10685987A IL106859A (en) 1986-12-31 1987-12-23 Pentoxifilin metabolites and pharmaceutical preparations containing them for the treatment of VIH and similar diseases
IL10053587A IL100535A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine to relieve disease states
IL8493487A IL84934A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines
IL10053387A IL100533A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states
IL10686187A IL106861A (en) 1986-12-31 1987-12-23 Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines

Family Applications After (6)

Application Number Title Priority Date Filing Date
IL10053687A IL100536A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine Stopping an immune response and relieving adverse conditions resulting from intracellular intervention in an immune response
IL10685987A IL106859A (en) 1986-12-31 1987-12-23 Pentoxifilin metabolites and pharmaceutical preparations containing them for the treatment of VIH and similar diseases
IL10053587A IL100535A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine to relieve disease states
IL8493487A IL84934A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines
IL10053387A IL100533A (en) 1986-12-31 1987-12-23 Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states
IL10686187A IL106861A (en) 1986-12-31 1987-12-23 Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines

Country Status (14)

Country Link
EP (1) EP0279079B1 (de)
JP (1) JP2507012B2 (de)
KR (1) KR960015726B1 (de)
AT (1) ATE151290T1 (de)
AU (1) AU668982B2 (de)
CA (1) CA1313137C (de)
DE (1) DE3752048T2 (de)
DK (1) DK482088A (de)
ES (1) ES2103255T3 (de)
GR (1) GR3024054T3 (de)
IE (1) IE873554L (de)
IL (7) IL106854A (de)
WO (1) WO1988004928A1 (de)
ZA (1) ZA879754B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
KR920702606A (ko) * 1989-06-13 1992-10-06 스튜어트 알. 슈터 모노킨(Monokine)의 활성저해
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
EP0493682A3 (en) * 1990-11-30 1992-11-19 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
EP0490181A1 (de) * 1990-11-30 1992-06-17 Hoechst-Roussel Pharmaceuticals Incorporated Verwendung von Xanthinen zur Herstellung eines Medikaments mit immunsuppressiver Wirkung
WO1992021344A2 (en) * 1991-05-24 1992-12-10 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
EP0518263A1 (de) * 1991-06-10 1992-12-16 Hoechst-Roussel Pharmaceuticals Incorporated Mikropellets und Verfahren zu ihrer Herstellung
WO1993003728A1 (en) * 1991-08-27 1993-03-04 Temple University Of The Commonwealth System Of Xanthine suppression of antigen activation of t- or b-cells
DK0610336T3 (da) * 1991-10-31 2002-07-22 Univ Manchester Behandling af neurologiske tilstande ved hjælp af en interleukin-1-hæmmende forbindelse
WO1996005836A2 (en) * 1994-08-25 1996-02-29 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
JP3830115B2 (ja) * 1997-10-06 2006-10-04 シャープ株式会社 液晶表示素子
TW561297B (en) * 1997-11-25 2003-11-11 Toshiba Corp Electrode wiring board subjected to counter measure against static electricity and display device using the same
JP3019053B2 (ja) * 1997-12-25 2000-03-13 日本電気株式会社 液晶表示装置及びその製造方法
EP2265334A2 (de) 2008-02-29 2010-12-29 Concert Pharmaceuticals, Inc. Substituierte xanthin-derivate
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
IN2012DN01642A (de) 2009-09-02 2015-06-05 Concert Pharmaceuticals Inc
US20130324564A1 (en) 2010-09-01 2013-12-05 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)-dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
CA2869874A1 (en) 2012-04-13 2013-10-17 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005015B1 (de) * 1978-04-22 1986-10-29 BEECHAM - WUELFING GmbH & Co. KG Verwendung eines Xanthinderivats für die Herstellung eines Arzneimittels
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment

Also Published As

Publication number Publication date
EP0279079A2 (de) 1988-08-24
AU637542B2 (en) 1993-05-27
ATE151290T1 (de) 1997-04-15
KR960015726B1 (ko) 1996-11-20
EP0279079A3 (de) 1990-06-13
DE3752048D1 (de) 1997-05-15
DK482088A (da) 1988-10-28
IL100535A (en) 1994-05-30
IL100536A (en) 1994-05-30
DK482088D0 (da) 1988-08-30
AU619732B2 (en) 1992-02-06
ES2103255T3 (es) 1997-09-16
JP2507012B2 (ja) 1996-06-12
CA1313137C (en) 1993-01-26
IL84934A (en) 1994-08-26
IL100533A (en) 1994-05-30
AU668982B2 (en) 1996-05-23
AU1291892A (en) 1992-05-14
IE873554L (en) 1988-06-30
IL106861A (en) 1997-02-18
AU1150588A (en) 1988-07-27
ZA879754B (en) 1989-07-26
WO1988004928A1 (en) 1988-07-14
GR3024054T3 (en) 1997-10-31
KR890700347A (ko) 1989-04-24
JPH02501829A (ja) 1990-06-21
AU4602793A (en) 1993-11-18
EP0279079B1 (de) 1997-04-09
IL106859A (en) 1996-10-16
DE3752048T2 (de) 1997-10-02

Similar Documents

Publication Publication Date Title
IL106854A (en) Pantoxifilin metabolites and pharmaceutical preparations containing them to prevent an immune reaction and to reduce undesirable conditions in this regard
US5096906A (en) Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) Method of inhibiting the activity of leukocyte derived cytokines
US5039666A (en) Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside
KR101160183B1 (ko) 마이코박테리아 저해제로서 사용하기 위한 퀴놀린 유도체
EP0550570A1 (de) Xanthinderivate
EP0475411B1 (de) Neue als Immunsuppressiva nützliche karbozyklische Adenosinanaloge
EP0490181A1 (de) Verwendung von Xanthinen zur Herstellung eines Medikaments mit immunsuppressiver Wirkung
US6420374B1 (en) Use of xanthines as immunosuppressants and to inhibit allograft reactions
EP0290558B1 (de) Antifolat-mittel
US4526964A (en) 2,4-Diamino-6-(hydroxymethyl)pyrido[2,3-d]pyrimidine
DE69119700T2 (de) Verwendung von Xanthinen zur Herstellung von Arzneimitteln zur Hemmung der Vermehrung menschlicher Retroviren
US5593999A (en) Non-classical folate analogue inhibitors of glycinamide ribonucleotide formyltransferase (GARFT)
Peters et al. The experimental chemotherapy of leishmaniasis, V: The activity of potential leishmanicides against ‘L. infantum LV9’in NMRI mice
US5196430A (en) Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) Method of inhibiting the activity of leukocyte derived cytokines
AU619732C (en) Method of inhibiting interleukin-1 activity
US4962112A (en) 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
US4628089A (en) Pyrido(2,3-D)pyrimidines
JPH0892250A (ja) 新規ピリド〔２，３−ｄ〕ピリミジン誘導体及びその製造方法
EP0075880A2 (de) Pyrido(2,3-d)pyrimidine
JPH06279287A (ja) 癌転移抑制剤
JPH05509108A (ja) ２，４−ジオキソ−ピリド［２，３−ｄ］ピリミジン−３−酢酸及びそのエステルと塩
JPH0723358B2 (ja) ピロールの新規アロイル誘導体
JPS61227522A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees